24 / 76
Dr. Cheryl Arrowsmith
Fellow
American Association for the Advancement
of Science
Dr. Steven Chan
Gilead Sciences Research Scholar in
Hematology/Oncology
Gilead Sciences Research Scholars Program
Dr. John Dick
Fellow
American Association for Cancer Research
(AACR) Academy
Dr. Peter Ferguson
Donald R. Wilson Award
Associated Medical Services and the Royal
College of Physicians and Surgeons of Canada
Dr. Mary Gospodarowicz
Officer of the Order of Canada
O. Harold Warwick Prize
Canadian Cancer Society Research Institute
Dr. Patrick Gullane
Order of Ontario
Dr. Hansen He
Early Research Award
Ministry of Innovation & Research
Dr. Michael Hoffman
Early Research Award
Ministry of Innovation & Research
Dr. Marianne Koritzinsky
Michael Fry Award
Radiation Research Society
Dr. Tak Mak
RBC Top 25 Canadian Immigrant Award
Breast Cancer Dream Team
Stand Up To Cancer
Steve Merker
One of the most influential Canadians
in cycling
Canadian Cycling Magazine
Dr. Hans Messner
Order of Ontario
Dr. Kieran Murphy
Leaders in Innovation Award
Society of Interventional Radiology Foundation
Dr. Gary Rodin
Mel Silverman Mentorship Award
University of Toronto
Susanna Sellmann
President-Elect
Society of Clinical Research Associates
Dr. Michael Sharpe
Fellow
American Association of Physicists in Medicine
Dr. Frances Shepherd
Officer of the Order of Canada
2015 Claude Jacquillat Award
International Congress on Anti-Cancer Treatment
Dr. Lillian Siu
Eaton Scholar Researcher of the Year
University of Toronto
Barbara Tiano
Torontonian of the Year
CBCMetro Morning
Dr. Ming Tsao
Mary Mathews Pathology Award
University of Toronto
Dr. Padraig Warde
Honorary Fellow, Faculty of Radiologists
Royal College of Surgeons in Ireland
Dr. Gang Zheng
Fellow
American Institute for Medical and
Biomedical Engineering
Honour Roll
20
2016 Report to Our Donors
Dr. Amit Oza is the new Head of Medical Oncology and Hematology for Princess Margaret
Cancer Centre. He is an internationally-renowned clinician scientist and also holds the
positions of Medical Director of the Cancer Clinical Research Unit and Co-Director of the
BRAS Drug Development Program at Princess Margaret Cancer Centre.
Dr. Oza was instrumental in establishing the Princess Margaret Phase II Consortium—a
pan-Canadian cancer research enterprise that has conducted more than 120 clinical trials.
Dr. Oza is well known for his expertise in gynecologic oncology and leads gynecology
committees for both the Canadian and U.S. National Cancer Institutes.
New leader for Medical Oncology and Hematology